This policy describes how a company should handle inspections to ensure a rapid, appropriate and professional response when an inspector arrives and throughout the duration of the audit. FDA's 2014 Guidance for Industry, Circumstances that consitute Delaying, Denying, Limiting, or Refusing a Drug Inspection allows regulatory action, if a company obstructs and inspector in conducting their duties.